| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Grant-A Ramm | |
| Marie-A Philippe | |||
| Richard-G Ruddell | |||
| P2860 | cites work | Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study | Q27477844 |
| CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells | Q28373260 | ||
| Identification and Characterization of the Hepatic Stellate Cell Transferrin Receptor | Q28567131 | ||
| A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis | Q28569215 | ||
| Liver fibrosis | Q29547449 | ||
| Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity | Q29614914 | ||
| Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein | Q29620682 | ||
| Liver fibrosis and altered matrix synthesis | Q34192858 | ||
| Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis | Q34200555 | ||
| Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes | Q34233556 | ||
| The chemistry and biological effects of malondialdehyde-acetaldehyde adducts | Q34272884 | ||
| Glutathione metabolism and its implications for health | Q34301684 | ||
| Oxidative stress-related molecules and liver fibrosis | Q34387346 | ||
| Hepatic stellate cell behavior during resolution of liver injury | Q34391401 | ||
| Role of malondialdehyde-acetaldehyde adducts in liver injury | Q34528016 | ||
| Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors | Q34580643 | ||
| Induction and regulation of hepatocyte apoptosis by oxidative stress | Q35019110 | ||
| Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells | Q35061964 | ||
| Hepatic stellate cells: unique characteristics in cell biology and phenotype | Q35155027 | ||
| Hemochromatosis and alcoholic liver disease | Q35212530 | ||
| Iron chelators and iron toxicity | Q35212539 | ||
| Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation | Q35356303 | ||
| Changes in serum iron levels due to infection with hepatitis B virus | Q35367944 | ||
| Hepatic steatosis in obese patients: clinical aspects and prognostic significance. | Q35669794 | ||
| Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice | Q35760220 | ||
| The natural history of chronic hepatitis C virus infection | Q35960890 | ||
| Iron metabolism and toxicity | Q35998155 | ||
| The emerging role of the liver in iron metabolism | Q36011776 | ||
| Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations | Q36116795 | ||
| Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. | Q36194280 | ||
| Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis | Q36325781 | ||
| Iron in nonhemochromatotic liver disorders | Q36325790 | ||
| Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes | Q36550366 | ||
| Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. | Q36588196 | ||
| Intracellular survival pathways in the liver | Q36653854 | ||
| Optimal duration of therapy in HBV-related cirrhosis | Q40215787 | ||
| Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. | Q40295951 | ||
| Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo | Q40312530 | ||
| Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2. | Q40572038 | ||
| Pathophysiology of iron toxicity. | Q40610814 | ||
| Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells | Q40758137 | ||
| Hepatic iron deposition in human disease and animal models | Q41068056 | ||
| Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury | Q41708777 | ||
| Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? | Q42285597 | ||
| Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis | Q42444554 | ||
| Experimental liver cirrhosis induced by alcohol and iron | Q42929412 | ||
| HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients | Q42991314 | ||
| Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein | Q43000585 | ||
| Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. | Q43039574 | ||
| Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection | Q43570543 | ||
| Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells | Q43826554 | ||
| Risk factors of fibrosis in alcohol-induced liver disease | Q43899930 | ||
| Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease | Q43929008 | ||
| Aldehydic products of lipid peroxidation do not directly activate rat hepatic stellate cells | Q44066562 | ||
| Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells | Q44138169 | ||
| Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease. | Q44363519 | ||
| Measurements of iron status in patients with chronic hepatitis | Q44529932 | ||
| Ethanol induces transforming growth factor-alpha expression in hepatocytes, leading to stimulation of collagen synthesis by hepatic stellate cells | Q44576558 | ||
| Regulatory failure of serum prohepcidin levels in patients with hepatitis C. | Q44722445 | ||
| Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. | Q45187496 | ||
| Effect of malondialdehyde-acetaldehyde-protein adducts on the protein kinase C-dependent secretion of urokinase-type plasminogen activator in hepatic stellate cells | Q45712502 | ||
| Hepatitis C virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda (PCT) | Q45874340 | ||
| Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages | Q46362946 | ||
| Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to lipopolysaccharide | Q46551763 | ||
| Steatosis is a cofactor in liver injury in hemochromatosis | Q46847690 | ||
| Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. | Q46909240 | ||
| Screening for hemochromatosis in asymptomatic subjects with or without a family history | Q46943195 | ||
| Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents | Q47993644 | ||
| Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases | Q50106577 | ||
| Change in the prevalence of overweight and obesity among young Australians, 1969-1997. | Q50195122 | ||
| Hepatic iron and nonalcoholic fatty liver disease. | Q50516617 | ||
| Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. | Q50530429 | ||
| Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. | Q50538402 | ||
| Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. | Q50910102 | ||
| Modulation of stellate cell proliferation and gene expression by rat hepatocytes: effect of toxic iron overload. | Q51834811 | ||
| Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. | Q53362654 | ||
| Corn oil rapidly activates nuclear factor-kappaB in hepatic Kupffer cells by oxidant-dependent mechanisms. | Q53417382 | ||
| Insulin resistance-associated hepatic iron overload. | Q54074092 | ||
| Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. | Q55033443 | ||
| Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells | Q61763109 | ||
| Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis | Q69995807 | ||
| Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis | Q70449933 | ||
| Rat liver ferritin selectively inhibits expression of alpha-smooth muscle actin in cultured rat lipocytes | Q71464366 | ||
| Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C | Q71699699 | ||
| Effect of nitric oxide on iron-mediated oxidative stress in primary rat hepatocyte culture | Q71949392 | ||
| Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis | Q72995518 | ||
| Pathogenesis of liver fibrosis | Q73129364 | ||
| Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial | Q73520267 | ||
| Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? | Q73572635 | ||
| Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy | Q73906595 | ||
| Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C | Q77540931 | ||
| Iron, hepatic stellate cells and fibrosis in chronic hepatitis C | Q77748127 | ||
| Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells | Q77933562 | ||
| Redox regulation of the caspases during apoptosis | Q77936057 | ||
| Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C | Q79264030 | ||
| Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells | Q79390715 | ||
| Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C | Q79420695 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4746-4754 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Role of iron in hepatic fibrosis: one piece in the puzzle | |
| P478 | volume | 13 |
| Q38381594 | Alcoholic liver disease: mechanisms of injury and targeted treatment |
| Q35199396 | Catecholamine stress hormones regulate cellular iron homeostasis by a posttranscriptional mechanism mediated by iron regulatory protein: implication in energy homeostasis |
| Q50554424 | Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C. |
| Q35440224 | Combined histological and hematological assessment of iron-induced organ damage in a gerbil model of iron overload |
| Q98945292 | Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease |
| Q46165720 | Deferoxamine alleviates liver fibrosis induced by CCl4 in rats. |
| Q35144263 | Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases |
| Q44481786 | Diagnosis of and therapy for hepatocellular carcinoma |
| Q57049148 | Dietary Iron Overload Abrogates Chemically-Induced Liver Cirrhosis in Rats |
| Q99549271 | Dietary Iron Overload Differentially Modulates Chemically-Induced Liver Injury in Rats |
| Q50142613 | Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis |
| Q26768466 | Early Detection of Hepatocellular Carcinoma: How to Screen and Follow up Patients with Liver Cirrhosis According to the GERMAN S3 Guideline? |
| Q34750585 | Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. |
| Q98895852 | Epigallocatechin Gallate Protects Mice against Methionine-Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate Hepatic Injury and Regulate Metabolism |
| Q91925896 | Evaluation of serum iron overload, AST:ALT ratio and log10ferritin:AST ratio among schizophrenia patients in the Kumasi Metropolis, Ghana: a case-control study |
| Q37240288 | Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells |
| Q42947256 | Hepatic iron loading in mice increases cholesterol biosynthesis. |
| Q24646056 | Hereditary hemochromatosis in the post-HFE era |
| Q64248770 | High Carbohydrate High Fat Diet Induced Hepatic Steatosis and Dyslipidemia Were Ameliorated by Psidium guajava Leaf Powder Supplementation in Rats |
| Q61798333 | Iron and liver fibrosis: Mechanistic and clinical aspects |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q91666114 | Iron overload reduces synthesis and elimination of bile acids in rat liver |
| Q42922519 | Iron: an emerging factor in colorectal carcinogenesis |
| Q82156525 | Non-alcoholic fatty liver disease: is iron relevant? |
| Q34626006 | Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders |
| Q34430634 | Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis |
| Q37022879 | Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization. |
| Q33629438 | Phlebotomy improves histology in chronic hepatitis C males with mild iron overload. |
| Q24656684 | Redox mechanisms in hepatic chronic wound healing and fibrogenesis |
| Q58775572 | Transient Elastography (TE) is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients |
Search more.